Efficacy of Ketogenic Diet, Modified Atkins Diet and Low Glycemic Index Therapy Diet Among Children With Drug Resistant Epilepsy: A Randomised Non-Inferiority Trial
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 165
- 试验地点
- 2
- 主要终点
- Percentage change in seizure frequency after 24 weeks of dietary therapy as compared to baseline, in the arm KD as compared to MAD and in the arm KD as compared to LGIT
研究概览
简要总结
This randomised trial is undertaken to assess whether MAD or LGIT is non-inferior to KD with regard to seizure control at twenty-four weeks among children with drug resistant epilepsy. The hypothesis of the study is that in 1 to 15-year-old children with drug resistant epilepsy, use of Modified Atkins Diet (MAD) or Low Glycemic Index Therapy (LGIT) as an add on to the ongoing anti-epileptic drugs would not be inferior to ketogenic diet by >15% in terms of seizure reduction from baseline seizure frequency at 24 weeks.
The primary outcome of the study is to determine the efficacy of MAD as compared to KD and LGIT as compared to KD for seizure reduction in drug resistant epilepsy following 24 weeks of dietary therapy in 1 to 15-year-old children on anti-epileptic drugs. The change in seizure frequency will be estimated as percentage change in seizure reduction at 24 weeks as compared to baseline.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 1 Year 至 15 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Children aged 1-15 years with drug resistant epilepsy (Drug resistant epilepsy for the study will be defined as seizure frequency >4 seizures per month, and treatment failure of ≥2 prescribed antiepileptic drugs).
- •Willing to come for regular follow up
排除标准
- •Surgically remediable cause for drug resistant epilepsy
- •Proven inborn error of metabolism except those in which KD is indicated (i.e., Pyruvate Carboxylase deficiency and GLUT-1 Deficiency)
- •Previously received KD, MAD or LGIT
- •Known case of
- •Chronic kidney disease
- •Chronic liver disease/ GI illness
- •Chronic heart disease (congenital and acquired)
- •Chronic respiratory illness
结局指标
主要结局
Percentage change in seizure frequency after 24 weeks of dietary therapy as compared to baseline, in the arm KD as compared to MAD and in the arm KD as compared to LGIT
时间窗: Baseline and six months
Percentage change in seizure frequency will be estimated as mean number of weekly seizures over preceding 4 weeks after 24 weeks of dietary therapy divided by mean number of weekly seizures over preceding 4 weeks at the baseline. It will be calculated for each of the three arms (KD; MAD; LGIT) and KD will compared to MAD and LGIT individually as the primary outcome.
次要结局
- Proportion of patients who achieve >50% seizure reduction from baseline at 24 weeks after diet initiation(Baseline and twenty-four weeks)
- Evaluate GI adverse events (diarrhoea, constipation and vomiting) assessed by parental questionnaire in each of the three arms at baseline and six months after therapy(Baseline and twenty-four weeks)
- Estimate behavior change as measured by Childhood behavior checklist in each of three arms at baseline, 12 weeks and 24 weeks after dietary therapy(Baseline, twelve weeks, and twenty-four weeks)
- Evaluate change in serum levels of micronutrients by laboratory testing in each of three arms at baseline and six months after therapy(Baseline and twenty-four weeks)
- Evaluate omega3 polyunsaturated fatty acid levels and correlate it with change in seizure frequency(Baseline and twenty-four weeks)
- Percentage change in seizure frequency after 24 weeks of dietary therapy as compared to baseline, in the arm MAD as compared to LGIT(Baseline and twenty-four weeks)
- Estimate cognition change as assessed by Vineland Social Maturity Scale in each of three arms at baseline, 12 weeks and 24 weeks after dietary therapy(Baseline and twenty-four weeks)
研究者
Sheffali Gulati
Professor
All India Institute of Medical Sciences, New Delhi